Key facts
- This page summarizes Elizabeth Hurlburt's Form 4 filing for CorMedix Inc. (CRMD).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 01 Sep 2026, 20:18.
Elizabeth Hurlburt - 29 Aug 2026 Form 4 Insider Report for CorMedix Inc. (CRMD)
- Reporting relationship
- Chief Operating Officer
- Issuer ticker
- CRMD
- Reported as of
- 29 Aug 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 01 Sep 2026, 20:18:27 UTC
- Prior SEC filing
- 06 Feb 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Beth Zelnick Kaufman, attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Elizabeth Hurlburt filed Form 4 for CorMedix Inc. (CRMD) on 01 Sep 2026.
Change
- Previous filing in this sequence was filed on 06 Feb 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001735256
Primary reporting owner
Hurlburt Elizabeth
- Relationship
- Chief Operating Officer
- Address
- C/O CORMEDIX INC., 389 INTERPACE PKWY, SUITE 450, PARSIPPANY
- Signature
- /s/ Beth Zelnick Kaufman, attorney-in-fact
- Signature date
- 01 Sep 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CRMD
transaction
Common Stock
Tax liability
- Transaction value
- Shares
- -8,076
- Change %
- -2.9%
- Price
- $8.30*
- Shares after
- 270,463
- Date
- 29 Aug 2026
- Ownership
- Direct
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
SEC remarks
Chief Operating & Commercial Officer